Growth pattern analysis of murine lung neoplasms by advanced semi-automated quantification of micro-CT images. Academic Article uri icon

Overview

abstract

  • Computed tomography (CT) is a non-invasive imaging modality used to monitor human lung cancers. Typically, tumor volumes are calculated using manual or semi-automated methods that require substantial user input, and an exponential growth model is used to predict tumor growth. However, these measurement methodologies are time-consuming and can lack consistency. In addition, the availability of datasets with sequential images of the same tumor that are needed to characterize in vivo growth patterns for human lung cancers is limited due to treatment interventions and radiation exposure associated with multiple scans. In this paper, we performed micro-CT imaging of mouse lung cancers induced by overexpression of ribonucleotide reductase, a key enzyme in nucleotide biosynthesis, and developed an advanced semi-automated algorithm for efficient and accurate tumor volume measurement. Tumor volumes determined by the algorithm were first validated by comparison with results from manual methods for volume determination as well as direct physical measurements. A longitudinal study was then performed to investigate in vivo murine lung tumor growth patterns. Individual mice were imaged at least three times, with at least three weeks between scans. The tumors analyzed exhibited an exponential growth pattern, with an average doubling time of 57.08 days. The accuracy of the algorithm in the longitudinal study was also confirmed by comparing its output with manual measurements. These results suggest an exponential growth model for lung neoplasms and establish a new advanced semi-automated algorithm to measure lung tumor volume in mice that can aid efforts to improve lung cancer diagnosis and the evaluation of therapeutic responses.

publication date

  • December 23, 2013

Research

keywords

  • Image Processing, Computer-Assisted
  • Lung Neoplasms
  • X-Ray Microtomography

Identity

PubMed Central ID

  • PMC3871568

Scopus Document Identifier

  • 84893510168

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0083806

PubMed ID

  • 24376755

Additional Document Info

volume

  • 8

issue

  • 12